Autoimmune thyroid disease following hematopoietic stem cell transplantation in childhood cancer survivors
- PMID: 35431444
- PMCID: PMC8981045
- DOI: 10.1297/cpe.2021-0059
Autoimmune thyroid disease following hematopoietic stem cell transplantation in childhood cancer survivors
Abstract
Thyroid dysfunction has been observed in childhood cancer survivors (CCSs) who have undergone hematopoietic stem cell transplantation (HSCT). We retrospectively analyzed the thyroid function of 54 CCSs who underwent HSCT and were referred to our endocrinology department at Chiba Children's Hospital between January 1, 2008, and December 31, 2019. Three patients developed autoimmune thyroid disease (AITD) after HSCT. Two of these patients had Graves' disease (GD), and the third had autoimmune thyroiditis. The association between HSCT and AITD remains unclear. All three patients had chronic graft versus host disease (GVHD). AITD was reported to be induced by the transmission of abnormal T or B lymphocyte clones from the donor to the recipient. One patient with GD was treated with a high dose of anti-thymocyte globulin (ATG). Some studies have reported that ATG is associated with a risk of severe T cell depletion and GD onset. In conclusion, CCSs who received HSCT rarely developed AITD. We suggest that CCSs treated with ATG and/or experiencing an onset of chronic GVHD should be carefully monitored for thyroid function because it might reveal AITD.
Keywords: Graves’ disease; autoimmune thyroid disease; autoimmune thyroiditis; childhood cancer survivors; hematopoietic stem cell transplantation.
2022©The Japanese Society for Pediatric Endocrinology.
Conflict of interest statement
None of the authors reports financial relationships relevant to this article.
Similar articles
-
Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation.Bone Marrow Transplant. 2005 Feb;35(4):383-8. doi: 10.1038/sj.bmt.1704766. Bone Marrow Transplant. 2005. PMID: 15640829
-
Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.Adv Immunol. 2016;129:175-249. doi: 10.1016/bs.ai.2015.08.003. Epub 2015 Dec 1. Adv Immunol. 2016. PMID: 26791860 Review.
-
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant. 2017 Dec;23(12):2096-2101. doi: 10.1016/j.bbmt.2017.08.007. Epub 2017 Aug 15. Biol Blood Marrow Transplant. 2017. PMID: 28821454
-
Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?Korean J Intern Med. 2016 Jul;31(4):750-61. doi: 10.3904/kjim.2015.234. Epub 2016 Mar 28. Korean J Intern Med. 2016. PMID: 27017944 Free PMC article.
-
Autoimmune thyroid disorders.Autoimmun Rev. 2015 Feb;14(2):174-80. doi: 10.1016/j.autrev.2014.10.016. Epub 2014 Oct 25. Autoimmun Rev. 2015. PMID: 25461470 Review.
Cited by
-
131I SUCCESSFULLY TREATED A CASE OF HYPERTHYROIDISM AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.Acta Endocrinol (Buchar). 2022 Apr-Jun;18(2):238-240. doi: 10.4183/aeb.2022.238. Acta Endocrinol (Buchar). 2022. PMID: 36212265 Free PMC article.
-
Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.Dig Dis Sci. 2024 Jun;69(6):2193-2203. doi: 10.1007/s10620-024-08439-0. Epub 2024 Apr 23. Dig Dis Sci. 2024. PMID: 38653947
-
Evolution of Graves' Disease during Immune Reconstitution following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in a Boy Carrying Germline SAMD9L and FLT3 Variants.Int J Mol Sci. 2022 Aug 22;23(16):9494. doi: 10.3390/ijms23169494. Int J Mol Sci. 2022. PMID: 36012751 Free PMC article.
References
-
- Suzuki S, Midorikawa S, Fukushima T, Shimura H, Ohira T, Ohtsuru A, et al. . Thyroid Examination Unit of the Radiation Medical Science Center for the Fukushima Health Management Survey. Systematic determination of thyroid volume by ultrasound examination from infancy to adolescence in Japan: the Fukushima Health Management Survey. Endocr J 2015;62: 261–8. doi: 10.1507/endocrj.EJ14-0478 - DOI - PubMed
LinkOut - more resources
Full Text Sources